Where is co.faktor located?

co.faktor is headquartered in Berlin, Germany.

Is co.faktor a funded company?

co.faktor is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does co.faktor rank among its competitors?

co.faktor ranks 505th amongst 1391 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of co.faktor?

co.faktor's top competitors include Indegene, IntegriChain and Clinigen. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

co.faktor - 2026 Company Profile & Competitors

Company Details

co.faktor GmbH is a company that provides solutions for the healthcare, pharmaceutical, and medical technology industries. They offer expertise and success in these sectors and are based in Berlin, Germany.

Website: cofaktor.de
Email ID: *****@cofaktor.de
Phone Number: +49 **********

Key Metrics

Location

Berlin, Germany

Stage

Acquired

Ranked

505^th among 1391 active competitors

Similar Companies

Indegene & 1650 more

Exit Details

Acquired by Cytel (Oct 02, 2023)

View co.faktor's full profile

co.faktor got acquired by Cytel on Oct 02, 2023.

Click here to take a look at co.faktor's acquisition in detail

co.faktor is a funded company.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of co.faktor include Indegene, IntegriChain and Clinigen. Here is the list of Top 10 competitors of co.faktor, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 18 others	78/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
3rd	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
4th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
5th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	57/100
6th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
7th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Bridgepoint Group, Intertrust & 8 others	56/100
8th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
9th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
10th	Spectrum Pharmatech Consultants 1995, Thane (India), Unfunded	Provider of diversified consulting services for biopharma sector	-	-	49/100
505th	co.faktor Berlin (Germany), Acquired	Provider of healthcare solutions for the pharmaceutical and medical technology industries.	-	-	21/100